Found 369 results
Doores KJ, Huber M, Le KM, Wang S-K, Doyle-Cooper C, Cooper A, Pantophlet R, Wong C-H, Nemazee D, Burton DR.  2013.  2G12-expressing B cell lines may aid in HIV carbohydrate vaccine design strategies.. J Virol. 87(4):2234-41.
Koff WC, Burton DR, Johnson PR, Walker BD, King CR, Nabel GJ, Ahmed R, Bhan MK, Plotkin SA.  2013.  Accelerating next-generation vaccine development for global disease prevention.. Science. 340(6136):1232910.
Kulp DW, Schief WR.  2013.  Advances in structure-based vaccine design.. Curr Opin Virol. 3(3):322-31.
Penaloza-MacMaster P, Provine NM, Ra J, Borducchi EN, McNally A, Simmons NL, Iampietro MJ, Barouch DH.  2013.  Alternative serotype adenovirus vaccine vectors elicit memory T cells with enhanced anamnestic capacity compared to Ad5 vectors.. J Virol. 87(3):1373-84.
Crispin M, Bowden TA.  2013.  Antibodies expose multiple weaknesses in the glycan shield of HIV.. Nat Struct Mol Biol. 20(7):771-2.
Klein F, Mouquet H, Dosenovic P, Scheid JF, Scharf L, Nussenzweig MC.  2013.  Antibodies in HIV-1 vaccine development and therapy.. Science. 341(6151):1199-204.
Gruell H, Bournazos S, Ravetch JV, Ploss A, Nussenzweig MC, Pietzsch J.  2013.  Antibody and antiretroviral preexposure prophylaxis prevent cervicovaginal HIV-1 infection in a transgenic mouse model.. J Virol. 87(15):8535-44.
Gavrilyuk J, Ban H, Uehara H, Sirk SJ, Saye-Francisco K, Cuevas A, Zablowsky E, Oza A, Seaman MS, Burton DR et al..  2013.  Antibody conjugation approach enhances breadth and potency of neutralization of anti-HIV-1 antibodies and CD4-IgG.. J Virol. 87(9):4985-93.
Shingai M, Nishimura Y, Klein F, Mouquet H, Donau OK, Plishka R, Buckler-White A, Seaman M, Piatak M, Lifson JD et al..  2013.  Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia.. Nature. 503(7475):277-80.
Ranasinghe S, Cutler S, Davis I, Lu R, Soghoian DZ, Qi Y, Sidney J, Kranias G, Flanders MD, Lindqvist M et al..  2013.  Association of HLA-DRB1-restricted CD4(+) T cell responses with HIV immune control.. Nat Med.
Julien J-P, Lee J H, Cupo A, Murin CD, Derking R, Hoffenberg S, Caulfield MJ, King RC, Marozsan AJ, Klasse P J et al..  2013.  Asymmetric recognition of the HIV-1 trimer by broadly neutralizing antibody PG9.. Proc Natl Acad Sci U S A. 110(11):4351-6.
Ota T, Doyle-Cooper C, Cooper AB, Doores KJ, Aoki-Ota M, Le K, Schief WR, Wyatt RT, Burton DR, Nemazee D.  2013.  B cells from knock-in mice expressing broadly neutralizing HIV antibody b12 carry an innocuous B cell receptor responsive to HIV vaccine candidates.. J Immunol. 191(6):3179-85.
Choi YSoo, Yang JA, Yusuf I, Johnston RJ, Greenbaum J, Peters B, Crotty S.  2013.  Bcl6 expressing follicular helper CD4 T cells are fate committed early and have the capacity to form memory.. J Immunol. 190(8):4014-26.
Ward AB, Sali A, Wilson IA.  2013.  Biochemistry. Integrative structural biology.. Science. 339(6122):913-5.
Malbec M, Porrot F, Rua R, Horwitz J, Klein F, Halper-Stromberg A, Scheid JF, Eden C, Mouquet H, Nussenzweig MC et al..  2013.  Broadly neutralizing antibodies that inhibit HIV-1 cell to cell transmission.. J Exp Med. 210(13):2813-21.
Julien J-P, Sok D, Khayat R, Lee J H, Doores KJ, Walker LM, Ramos A, Diwanji DC, Pejchal R, Cupo A et al..  2013.  Broadly Neutralizing Antibody PGT121 Allosterically Modulates CD4 Binding via Recognition of the HIV-1 gp120 V3 Base and Multiple Surrounding Glycans.. PLoS Pathog. 9(5):e1003342.
Feng Y, Forsell MNE, Flynn B, Adams W, Loré K, Seder R, Wyatt RT, Karlsson Hedestam GB.  2013.  Chemical cross-linking of HIV-1 Env for direct TLR7/8 ligand conjugation compromises recognition of conserved antigenic determinants.. Virology. 446(1-2):56-65.
Ringe RP, Sanders RW, Yasmeen A, Kim HJ, Lee J H, Cupo A, Korzun J, Derking R, van Montfort T, Julien J-P et al..  2013.  Cleavage strongly influences whether soluble HIV-1 envelope glycoprotein trimers adopt a native-like conformation.. Proc Natl Acad Sci U S A. 110(45):18256-61.
Tan WG, Jin H-T, West EE, Penaloza-MacMaster P, Wieland A, Zilliox MJ, McElrath JM, Barouch DH, Ahmed R.  2013.  Comparative analysis of simian immunodeficiency virus gag-specific effector and memory CD8+ T cells induced by different adenovirus vectors.. J Virol. 87(3):1359-72.
West AP, Scharf L, Horwitz J, Klein F, Nussenzweig MC, Bjorkman PJ.  2013.  Computational analysis of anti-HIV-1 antibody neutralization panel data to identify potential functional epitope residues.. Proc Natl Acad Sci U S A. 110(26):10598-603.
Ferguson AL, Falkowska E, Walker LM, Seaman MS, Burton DR, Chakraborty AK.  2013.  Computational prediction of broadly neutralizing HIV-1 antibody epitopes from neutralization activity data.. PLoS One. 8(12):e80562.
Lyumkis D, Julien J-P, de Val N, Cupo A, Potter CS, Klasse P-J, Burton DR, Sanders RW, Moore JP, Carragher B et al..  2013.  Cryo-EM structure of a fully glycosylated soluble cleaved HIV-1 envelope trimer.. Science. 342(6165):1484-90.
Julien J-P, Cupo A, Sok D, Stanfield RL, Lyumkis D, Deller MC, Klasse P-J, Burton DR, Sanders RW, Moore JP et al..  2013.  Crystal Structure of a Soluble Cleaved HIV-1 Envelope Trimer.. Science.
Choi YSoo, Eto D, Yang JA, Lao C, Crotty S.  2013.  Cutting edge: STAT1 is required for IL-6-mediated Bcl6 induction for early follicular helper cell differentiation.. J Immunol. 190(7):3049-53.